PLAYA DEL CARMEN, Mexico, March 14, 2024 (GLOBE NEWSWIRE) -- David Dardashti describes his discovery of ibogaine treatment for long term opiates. In recent years, David has identified a series of carefully calibrated interconnections between opiates and other medications. Through an extensive study of the neurological pathways generated by long-term opiate use, he discovered a unique combination of medications and reactions that can effectively disconnect the pathways prior to ibogaine treatment.

墨西哥卡门海滩，2024年3月14日（环球通讯社）——大卫·达达什蒂（DavidDardashti）描述了他发现的伊博加因治疗长期阿片类药物的方法。近年来，David已经确定了阿片类药物和其他药物之间一系列经过仔细校准的相互关系。通过对长期使用阿片类药物产生的神经通路的广泛研究，他发现了一种独特的药物和反应组合，可以在伊博加因治疗之前有效地切断通路。

This in turn can lead to a more successful ibogaine treatment when compared to short-term opiate treatments. Lead ibogaine manufacturer in Gabon and chemical engineer, Pore, adds, 'I have witnessed tremendous projects involving the chemical engineering of medicine and was shocked to learn David’s approach through use of simple ingredients.' David found that 99.9 percent pure ibogaine was far more effective than other distributors, citing its remarkable ability to dissolve the complex neurological pathways of long-term opiate use.

与短期阿片类药物治疗相比，这反过来可以导致更成功的伊博加因治疗。加蓬ibogaine的主要制造商兼化学工程师Pore补充说，“我目睹了涉及医学化学工程的巨大项目，并对David使用简单成分的方法感到震惊。”David发现99.9%的纯伊博加因比其他分销商有效得多，理由是它具有显着的溶解长期使用阿片类药物的复杂神经通路的能力。

David discovered an effective combination of medications that can effectively disconnect the neurological pathways created by long-term opiate use, to enable a successful ibogaine treatment prior to the use of ibogaine. Ibogaine By David Dardashti is seeking out qualified clinicians to explore the powerful effects of pure ibogaine hydrochloride on long-term opiate abuse.

David发现了一种有效的药物组合，可以有效地切断长期使用阿片类药物产生的神经通路，从而在使用伊博加因之前成功进行伊博加因治疗。DavidDardashti的Ibogaine正在寻找合格的临床医生，以探索纯盐酸伊博加因对长期阿片类药物滥用的强大作用。

Those interested in the research, please contact for further details. Gavriel Dardashti+17869301880gavriel@ibogaineclinic.com A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/115eb74f-ff4b-4061-87a8-8c3633fddf63 .

对研究感兴趣的人，请联系以了解更多详细信息。加夫里尔·达达什蒂+17869301880gavriel@ibogaineclinic.com有关此公告的照片，请访问https://www.globenewswire.com/NewsRoom/AttachmentNg/115eb74f-ff4b-4061-87a8-8c3633fddf63。